Key statistics
As of last trade, Applied Therapeutics Inc (APLT:NMQ) traded at 0.4118, 39.59% above the 52 week low of 0.295 set on Apr 16, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.421 |
---|---|
High | 0.438 |
Low | 0.34 |
Bid | 0.4118 |
Offer | 0.4145 |
Previous close | 0.421 |
Average volume | 2.15m |
---|---|
Shares outstanding | 141.58m |
Free float | 110.26m |
P/E (TTM) | -- |
Market cap | 59.60m USD |
EPS (TTM) | -0.3023 USD |
Data delayed at least 15 minutes, as of Jul 15 2025 20:29 BST.
More ▼
- Applied Therapeutics Announces Key Leadership Appointments
- Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
- Applied Therapeutics Reports First Quarter 2025 Financial Results
- Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
- Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
- Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
- Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
- Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality
- Applied Therapeutics Appoints John H. Johnson as Executive Chairman
- Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
More ▼